Uncovering moderators of organisational ambidexterity: evidence from the pharmaceutical industry

被引:19
|
作者
Suzuki, Osamu [1 ]
机构
[1] Kwansei Gakuin Univ, Inst Business & Accounting, Nishinomiya, Hyogo, Japan
关键词
Ambidexterity; exploitation; exploration; innovation; competitive advantage; STRUCTURAL INERTIA; RISK-TAKING; EXPLORATION; EXPLOITATION; SEARCH; PERFORMANCE; FLEXIBILITY; KNOWLEDGE; ADAPTATION; CAPABILITY;
D O I
10.1080/13662716.2018.1431525
中图分类号
F [经济];
学科分类号
02 ;
摘要
Our manuscript advances the growing literature on organisational ambidexterity by arguing that organisational ambidexterity more positively influences organisational performance when there are more learning obstacles to pursue both exploitation and exploration. Extending this argument, we identify five conditions under which organisational ambidexterity more positively influences long-term organisational performance. The conditions include the degree of environmental dynamism, competition, organisational size, organisational slack and organisational senescence. An empirical analysis of 50 pharmaceutical firms' new product development characteristics and financial performance over a 20-year period supports our argument. Our findings inform future research on organisational ambidexterity by more specifically explaining the way in which organisational ambidexterity enables organisational survival and prosperity.
引用
收藏
页码:391 / 418
页数:28
相关论文
共 50 条
  • [31] Flexible work hours and productivity: Some evidence from the pharmaceutical industry
    Shepard, EM
    Clifton, TJ
    Kruse, D
    [J]. INDUSTRIAL RELATIONS, 1996, 35 (01): : 123 - 139
  • [32] THE EFFECTS OF PERCEIVED ORGANISATIONAL SUPPORT ON EMPLOYEES' AFFECTIVE OUTCOMES: EVIDENCE FROM THE HOTEL INDUSTRY
    Colakoglu, Ulker
    Culha, Osman
    Atay, Hakan
    [J]. TOURISM AND HOSPITALITY MANAGEMENT-CROATIA, 2010, 16 (02): : 125 - 150
  • [33] Trust and control in evolving inter-organisational relationships: Evidence from the aerospace industry
    Varoutsa, Evangelia
    Scapens, Robert W.
    [J]. ACCOUNTING AUDITING & ACCOUNTABILITY JOURNAL, 2018, 31 (01): : 112 - 140
  • [34] How do irresponsibility attributions affect organisational reputation? Evidence from the banking industry
    Zasuwa, Grzegorz
    Wesolowski, Grzegorz
    [J]. INTERNATIONAL JOURNAL OF BANK MARKETING, 2024, 42 (06) : 1370 - 1387
  • [35] Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis
    Bianchi, Mattia
    Cavaliere, Alberto
    Chiaroni, Davide
    Frattini, Federico
    Chiesa, Vittorio
    [J]. TECHNOVATION, 2011, 31 (01) : 22 - 33
  • [36] Can the spending of corporate social responsibility be offset? Evidence from pharmaceutical industry
    Yang, Minghui
    Wang, Jiawen
    Maresova, Petra
    Akbar, Minhas
    [J]. ECONOMIC RESEARCH-EKONOMSKA ISTRAZIVANJA, 2022, 35 (01): : 6279 - 6303
  • [37] R&D and firm performance: evidence from the Indian pharmaceutical industry
    Sharma, Chandan
    [J]. JOURNAL OF THE ASIA PACIFIC ECONOMY, 2012, 17 (02) : 332 - 342
  • [38] Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry
    Branstetter, Lee
    Chatterjee, Chirantan
    Higgins, Matthew J.
    [J]. RAND JOURNAL OF ECONOMICS, 2016, 47 (04): : 857 - 890
  • [39] Firm value and geographic competitive advantage: Evidence from the US pharmaceutical industry
    Boasson, V
    Boasson, E
    MacPherson, A
    [J]. JOURNAL OF BUSINESS, 2005, 78 (06): : 2465 - 2495
  • [40] Incentive effects of government subsidy on technological innovation: Evidence from pharmaceutical industry
    Yang, Tingting
    Xu, Botong
    [J]. FINANCE RESEARCH LETTERS, 2023, 55